Localization of dipeptidyl peptidase-4 (CD26) to human pancreatic ducts and islet alpha cells

Diabetes Research and Clinical Practice

Volumn 110, Issue 3, 2015, Pages 291-300

  Augstein, Petra ^a,b   Naselli, Gaetano ^a   Loudovaris, Thomas ^c   Hawthorne, Wayne J ^d   Campbell, Peter ^c   Bandala Sanchez, Esther ^a   Rogers, Kelly ^a   Heinke, Peter ^b   Thomas, Helen E ^c   Kay, Thomas W ^c   Harrison, Leonard C ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Institut fur Diabetes 'Gerhardt Katsch'   (Germany)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Alpha cell; Beta cell; CD26; Dipeptidyl peptidase 4; Human pancreas; Islet

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCAGON; DPP4 PROTEIN, HUMAN; GLUCAGON LIKE PEPTIDE 1; INCRETIN; PROINSULIN;

ADULT; AGED; ARTICLE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; ENZYME LOCALIZATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS DUCT; PANCREAS ISLET ALPHA CELL; PROTEIN EXPRESSION; YOUNG ADULT; METABOLISM; PANCREAS ISLET BETA CELL; PANCREATIC DUCT;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL PEPTIDASE 4; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-SECRETING CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INCRETINS; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; PANCREATIC DUCTS; PROINSULIN; YOUNG ADULT;

EID: 84955203121     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.10.010     Document Type: Article

References (40)

1. Hopsu-Havu V.K., Glenner G.G. A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie 1966, 7:197-201.
2. Schrader W.P., Stacy A.R. Purification and subunit structure of adenosine deaminase from human kidney. J Biol Chem 1977, 252:6409-6415.
3. Ben-Shooshan I., Parola A.H. The CP-I subunit of adenosine deaminase complexing protein from calf kidney is identical to human, mouse, and rat dipeptidyl peptidase IV. Comp Biochem Physiol B Biochem Mol Biol 1998, 119:289-292.
4. Holst J.J. The physiology of glucagon-like peptide 1. Physiol Rev 2007, 87:1409-1439.
5. Mentzel S., Dijkman H.B., Van Son J.P., Koene R.A., Assmann K.J. Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice. J Histochem Cytochem 1996, 44:445-461.
6. Matteucci E., Giampietro O. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr Med Chem 2009, 16:2943-2951.
7. Kameoka J., Tanaka T., Nojima Y., Schlossman S., Morimoto C. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 1993, 261:466-469.
8. Yu D.M.T., Yao T-W., Chowdhury S., Nadvi N.A., Osborne B., Church W.B., et al. The dipeptidyl peptidase IV family in cancer and cell biology. FEBS J 2010, 277:1126-1144.
9. Deacon C.F., Holst J.J. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety. Expert Opin Pharmacother 2013, 14:2047-2058.
10. Meier J.J. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol 2012, 8:728-742.
11. Nauck M.A. Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications. Am J Med 2011, 124:S3-S18.
12. Schrader W.P., West C.A. Adenosine deaminase complexing proteins are localized in exocrine glands of the rabbit. J Histochem Cytochem 1985, 33:508-514.
13. Dorrell C., Grompe M.T., Pan F.C., Zhong Y., Canaday P.S., Shultz L.D., et al. Isolation of mouse pancreatic alpha, beta, duct and acinar populations with cell surface markers. Mol Cell Endocrinol 2011, 339:144-150.
14. Poulsen M.D., Hansen G.H., Dabelsteen E., Høyer P.E., Norén O., Sjöström H. Dipeptidyl peptidase IV is sorted to the secretory granules in pancreatic islet A-cells. J Histochem Cytochem 1993, 41:81-88.
15. Dinjens W.N., Kate ten J., van der Linden E.P., Wijnen J.T., Khan P.M., Bosman F.T. Distribution of adenosine deaminase complexing protein (ADCP) in human tissues. J Histochem Cytochem 1989, 37:1869-1875.
16. Bramswig N.C., Everett L.J., Schug J., Dorrell C., Liu C., Luo J., et al. Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Investig 2013, 123:1275-1284.
17. Omar B., Ohlsson L., Yamada Y., Seino Y., Ahren B. Direct enhancement of insulin secretion by dipeptidyl peptidase 4 inhibitors in pancreatic islets: studies in incretin receptor deficient mice. Diabetologia 2013, 56:S24. (Abstract 44).
18. Augstein P., Naselli G., Loudovaris T., Campbell P.D., Rogers K., Bandala-Sanchez E., et al. DPP-4 (CD26) is expressed by ductal and islet cells in human adult pancreas. Annual meeting of the EASD Islet Study Group 2012, 4.1.
19. Augstein P., Naselli G., Loudovaris T., Campbell P., Bandala-Sanchez E.M., Heinke P., et al. DPP-4 (CD26) is expressed by ductal and islet cells in human adult pancreas. Diabetologia 2013, 56:S216. (Abstract 521).
20. Omar A.B., Liehua L., Yamade Y., Seino Y., Marchetti P., Ahren B. Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes. Diabetologia 2014, 57:1876-1883.
21. Campbell P.D., Weinberg A., Chee J., Mariana L., Ayala R., Hawthorne W.J., et al. Expression of pro- and antiapoptotic molecules of the Bcl-2 family in human islets postisolation. Cell Transpl 2012, 21:49-60.
22. Gunton J.E., Kulkarni R.N., Yim S., Okada T., Hawthorne W.J., Tseng Y-H., et al. Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005, 122:337-349.
23. Dorrell C., Abraham S.L., Lanxon-Cookson K.M., Canaday P.S., Streeter P.R., Grompe M. Isolation of major pancreatic cell types and long-term culture-initiating cells using novel human surface markers. Stem Cell Res 2008, 1:183-194.
24. Madsen O.D., Frank B.H., Steiner D.F. Human proinsulin-specific antigenic determinants identified by monoclonal antibodies. Diabetes 1984, 33:1012-1016.
25. Augstein P., Ziegler B., Schlosser M., Flassig S., Strebelow M., Ziegler M. Immunohistochemical differentiation of monoclonal GAD antibodies recognizing linear or conformational epitope regions. Pancreas 1997, 15:139-146.
26. Collins T. Colocalisation Available from: . [accessed 12.11.2012]. http://www.macbiophotonics.ca/imagej.
27. Meier J.J., Nauck M.A. Is secretion of glucagon-like peptide-1 reduced in type 2 diabetes mellitus?. Nat Clin Pract Endocrinol Metab 2008, 4:606-607.
28. Nauck M.A., Vardarli I., Deacon C.F., Holst J.J., Meier J.J. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?. Diabetologia 2011, 54:10-18.
29. Drucker DJ. Deciphering metabolic messages from the gut drives therapeutic innovation: the 2014 Banting Lecture. Diabetes n.d.;64:317-26.
30. Marchetti P., Lupi P., Bugliani M., Kirkpatrick C.L., Sebastiani G., Grieco F.A., et al. A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia 2013, 55:3262-3272.
31. Vollmer K., Holst J.J., Baller B., Ellrichmann M., Nauck M.A., Schmidt W.E., et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008, 57:678-687.
32. Lardon J., Corbeil D., Hutter W.B., Ling Z. Stem cell marker prominin-1/AC133 is expressed in duct cells of the adult human pancreas. Pancreas 2008, 36:1-6.
33. Gorrell M.D. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clinical Science 2005, 108:277.
34. Banakh I., Gonez L.J., Sutherland M.R., Naselli G., Harrison L.C. Adult pancreas side population cells expand after β cell injury and are a source of insulin-secreting cells. PLoS ONE 2012, 1-74.
35. Pang R., Law W.L., Chu A.C.Y., Poon J.T., Lam C.S.C., Chow A.K.M., et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Stem Cell 2010, 6:603-615.
36. Kucia M., Reca R., Miekus K., Wanzeck J., Wojakowski W., Janowska-Wieczorek A., et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005, 23:879-894.
37. Lysy P.A., Weir G.C., Bonner-Weir S. Concise review: pancreas regeneration: recent advances and perspectives. Stem Cells Transl Med 2012, 1:150-159.
38. Kong B., Michalski C.W., Erkan M., Friess H., Kleeff J. From tissue turnover to the cell of origin for pancreatic cancer. Nat Rev Gastroenterol Hepatol 2011, 8:467-472.
39. Gier B., Butler A.E., Matveyenko A.V., Kirakossian D., Dry S.M., Atkinson M.A., et al. Pancreatic duct glands - a stem cell niche in the pancreas?. Diabetologia 2012, 55:S180(A425).
40. Egan A.G., Blind E., Dunder K., de Graeff P.A., Hummer B.T., Bourcier T., et al. Pancreatic safety of incretin-based drugs - FDA and EMA assessment. N Engl J Med 2015, 370:794-797.